A Stepwise Workflow for Optimizing Multiplex RT-qPCR-Based Gene Expression Analysis: From Primer Concentrations to RNA Extraction Method Selection
Year: 2026
Type: preprint
Abstract: Multiplex reverse transcription quantitative PCR (RT-qPCR) is a cornerstone of molecular diagnostics, yet its reliability depends on systematic optimization. Here, we present a stepwise workflow for optimizing a multiplex RT-qPCR assay for MTOR (mechanistic target of rapamycin) gene expression analysis, normalized to RPLP0 (ribosomal protein lateral stalk subunit P0) and TBP (TATA-box binding protein). The workflow comprised four sequential stages: amplification protocol refinement, primer concentration and probe:primer ratio titration, comparative assessment of three RNA extraction methods (phenol-chloroform extraction, isopropanol precipitation, and silica-membrane spin-columns) across blood, cell cultures, and tumor tissue, and evaluation of DNase treatment necessity. Optimal conditions yielded amplification efficiencies of 97% for MTOR, 92% for RPLP0, and 84.3% for TBP with high linearity (R² ≥ 0.97). Phenol-chloroform extraction provided the highest RNA purity (A260/A280 1.8–2.0), completely eliminated genomic DNA from blood and cell culture samples, and ensured the best reproducibility for blood (interquartile range, IQR = 13.2%). Spin-columns offered the best balance for cell cultures (IQR = 22.5%). Isopropanol precipitation produced the highest RNA yield for both blood and cell culture samples but caused significant DNA contamination and poor linearity for blood samples (R² = 0.55–0.58). DNase treatment was dispensable when using intron-overlapping primers, as genomic DNA contribution did not exceed technical variability for phenol-chloroform and spin-column methods. Sanger sequencing confirmed 100% specificity of all amplification products. The proposed stepwise workflow provides a practical framework for the development of reliable multiplex RT-qPCR assays.
Source: Research Square
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
OpenAlex ID: W7235654335
